Evaluating Ai-driven Design and Discovery Tools in RNA Therapeutics

This TIDES Spring 2025 webinar brings together leading experts to explore the future of oligonucleotide and peptide therapeutics. Featuring Generoso Ianniciello, Chief Business Officer of Anima Biotech, the panel highlights how AI-driven design and discovery tools are reshaping RNA therapeutics. Speakers share strategic perspectives on overcoming development challenges, accelerating innovation, and positioning these modalities to transform the next generation of medicines, offering valuable insights for scientists, biotech leaders, and the broader life sciences community.